Joshua M Fine - Net Worth and Insider Trading

Joshua M Fine Net Worth

The estimated net worth of Joshua M Fine is at least $22,815 dollars as of 2024-05-28. Joshua M Fine is the CFO of Cyclo Therapeutics Inc and owns about 16,900 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $22,815. Details can be seen in Joshua M Fine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua M Fine has not made any transactions after 2021-03-29 and currently still holds the listed stock(s).

Transaction Summary of Joshua M Fine

To

Joshua M Fine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua M Fine owns 1 companies in total, including Cyclo Therapeutics Inc (CYTH) .

Click here to see the complete history of Joshua M Fine’s form 4 insider trades.

Insider Ownership Summary of Joshua M Fine

Ticker Comapny Transaction Date Type of Owner
CYTH Cyclo Therapeutics Inc 2021-03-29 Chief Financial Officer

Joshua M Fine Latest Holdings Summary

Joshua M Fine currently owns a total of 1 stock. Joshua M Fine owns 16,900 shares of Cyclo Therapeutics Inc (CYTH) as of March 29, 2021, with a value of $22,815.

Latest Holdings of Joshua M Fine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTH Cyclo Therapeutics Inc 2021-03-29 16,900 1.35 22,815

Holding Weightings of Joshua M Fine


Joshua M Fine Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua M Fine has made a total of 2 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 50 shares on March 29, 2021, which cost Joshua M Fine around $370.

Insider Trading History of Joshua M Fine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua M Fine Trading Performance

GuruFocus tracks the stock performance after each of Joshua M Fine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua M Fine is 33.05%. GuruFocus also compares Joshua M Fine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua M Fine within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua M Fine's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua M Fine

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.22
Relative Return to S&P 500(%) -7.25

Joshua M Fine Ownership Network

Ownership Network List of Joshua M Fine

No Data

Ownership Network Relation of Joshua M Fine


Joshua M Fine Owned Company Details

What does Cyclo Therapeutics Inc do?

Who are the key executives at Cyclo Therapeutics Inc?

Joshua M Fine is the Chief Financial Officer of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .

Cyclo Therapeutics Inc (CYTH) Insider Trades Summary

Over the past 18 months, Joshua M Fine made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 299,402 shares made by N Scott Fine , and a net purchase of 59,881 shares made by Markus Sieger .

In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.

Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclo Therapeutics Inc Insider Transactions

No Available Data

Joshua M Fine Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua M Fine. You might contact Joshua M Fine via mailing address: 21 Hemmelskamp Road, Wilton Ct 06897.

Discussions on Joshua M Fine

No discussions yet.